irinotecan hydrochloride trihydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial AUST R: 209857Active ingredients:
irinotecan hydrochloride trihydrate
Dosage form:
Injection, concentrated
Sponsor:
Accord Healthcare Pty Ltd
Phone:
1800 222 673
|
From
02 Jun 2025
to
31 Aug 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
An alternative strength is available.
|
IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial AUST R: 316412Active ingredients:
irinotecan hydrochloride trihydrate
Dosage form:
Injection, concentrated
Sponsor:
Accord Healthcare Pty Ltd
Phone:
1800 222 673
|
From
07 Mar 2025
to
15 May 2025
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 100 mg / 5 mL injection vial AUST R: 167202Active ingredients:
irinotecan hydrochloride trihydrate
Dosage form:
Injection
Sponsor:
Cipla Australia Pty Ltd
Phone:
03 9696 4413
|
Deletion from market:
12 Jun 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
An alternative brand is available.
|